Eli Lilly

The website is targeted at consumers looking to buy drugs without using insurance

The Danish firm’s complacency is its undoing in the weight-loss drug war

The investment plan comes days after US President Donald Trump announced a 100% tariff on imported branded or patented drugs

[WASHINGTON] President Donald Trump sent letters to the leaders of 17 major pharmaceutical companies outlining how they should slash US prescription drug prices to match those paid overseas, the White...

ELI Lilly is spending another US$3 billion to build out its US manufacturing footprint as it ramps up production of its blockbuster diabetes and weight-loss drugs.

ELI Lilly expects to start selling its highly popular weight-loss drug in Hong Kong as early as the end of this year, potentially making it the first of its kind to become available in the China regio...

It expects the facility to streamline manufacturing processes and increase capacity for clinical trial medicines

Eli Lilly’s weight-loss drug, Zepbound, drastically cut the risk of developing type 2 diabetes in overweight or obese pre-diabetic adults after three years of weekly injections, the drugmaker said on ...

ELI Lilly & Co agreed to buy US gut-drug maker Morphic Holding for about US$3.2 billion, ploughing some of the proceeds from obesity blockbuster Zepbound into its experimental pipeline.